(Q33372766)

26 July 2017

title

Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C. (English)

1 reference

26 July 2017

C G Nudo

1

1 reference

26 July 2017

P Wong

series ordinal

2

1 reference

26 July 2017

N Hilzenrat

series ordinal

3

1 reference

26 July 2017

M Deschênes

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Canadian Journal of Gastroenterology

26 July 2017

published in

0 references

volume

20

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

589-592

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

26 July 2017

copyright license

start time

1 January 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Understudied populations with hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Limited success of HCV antiviral therapy in United States veterans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Interferon therapy for patients more than 60 years of age with chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Chronic hepatitis. An update on terminology and reporting.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Treatment of Hepatitis C Virus in Elderly Persons With Interferon

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2659944

Management of hepatitis C

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17001400

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17001400

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hepatitis C--global prevalence (update)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17001400

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2006/357259

1 reference

26 July 2017

1 reference

26 July 2017

1 reference